miR-199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced Lung Fibroblast Activation by Targeting Caveolin-1

English version České info

As miRNAs are associated with normal cellular processes, deregulation of miRNAs is thought to play a causative role in many complex diseases. Nevertheless, the precise contribution of miRNAs in fibrotic lung diseases, especially the idiopathic form (IPF), remains poorly understood. Given the poor response rate of IPF patients to current therapy, new insights into the pathogenic mechanisms controlling lung fibroblasts activation, the key cell type driving the fibrogenic process, are essential to develop new therapeutic strategies for this devastating disease. To identify miRNAs with potential roles in lung fibrogenesis, we performed a genome-wide assessment of miRNA expression in lungs from two different mouse strains known for their distinct susceptibility to develop lung fibrosis after bleomycin exposure. This led to the identification of miR-199a-5p as the best miRNA candidate associated with bleomycin response. Importantly, miR-199a-5p pulmonary expression was also significantly increased in IPF patients (94 IPF versus 83 controls). In particular, levels of miR-199a-5p were selectively increased in myofibroblasts from injured mouse lungs and fibroblastic foci, a histologic feature associated with IPF. Therefore, miR-199a-5p profibrotic effects were further investigated in cultured lung fibroblasts: miR-199a-5p expression was induced upon TGFβ exposure, and ectopic expression of miR-199a-5p was sufficient to promote the pathogenic activation of pulmonary fibroblasts including proliferation, migration, invasion, and differentiation into myofibroblasts. In addition, we demonstrated that miR-199a-5p is a key effector of TGFβ signaling in lung fibroblasts by regulating CAV1, a critical mediator of pulmonary fibrosis. Remarkably, aberrant expression of miR-199a-5p was also found in unilateral ureteral obstruction mouse model of kidney fibrosis, as well as in both bile duct ligation and CCl₄-induced mouse models of liver fibrosis, suggesting that dysregulation of miR-199a-5p represents a general mechanism contributing to the fibrotic process. MiR-199a-5p thus behaves as a major regulator of tissue fibrosis with therapeutic potency to treat fibroproliferative diseases.

Vyšlo v časopise: miR-199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced Lung Fibroblast Activation by Targeting Caveolin-1. PLoS Genet 9(2): e32767. doi:10.1371/journal.pgen.1003291
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003291

Souhrn

Zdroje

1. WynnTA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524–529.

2. WilsonMS, WynnTA (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103–121.

3. KisK, LiuX, HagoodJS (2011) Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med 13: e27.

4. WightmanB, HaI, RuvkunG (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855–862.

5. LeeRC, FeinbaumRL, AmbrosV (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843–854.

6. Griffiths-JonesS (2006) miRBase: the microRNA sequence database. Methods Mol Biol 342: 129–138.

7. SayedD, AbdellatifM (2011) MicroRNAs in development and disease. Physiol Rev 91: 827–887.

8. Esquela-KerscherA, SlackFJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259–269.

9. SheedyFJ, O'NeillLA (2008) Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 67Suppl 3: iii50–iii55.

10. O'ConnellRM, ChaudhuriAA, RaoDS, GibsonWS, BalazsAB, et al. (2010) MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci U S A 107: 14235–14240.

11. HatleyME, PatrickDM, GarciaMR, RichardsonJA, Bassel-DubyR, et al. (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282–293.

12. PichiorriF, SuhSS, RocciA, DeLL, TaccioliC, et al. (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18: 367–381.

13. PanditKV, CorcoranD, YousefH, YarlagaddaM, TzouvelekisA, et al. (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 220–229.

14. LiuG, FriggeriA, YangY, MilosevicJ, DingQ, et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589–1597.

15. ThumT, GrossC, FiedlerJ, FischerT, KisslerS, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980–984.

16. LawsonWE, BlackwellTS, GauldieJ (2011) Let It Be: microRNAs Impact Interstitial Lung Disease. Am J Respir Crit Care Med 183: 1–2.

17. PanditKV, MilosevicJ, KaminskiN (2011) MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157: 191–199.

18. DrabM, VerkadeP, ElgerM, KasperM, LohnM, et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449–2452.

19. WangXM, ZhangY, KimHP, ZhouZ, Feghali-BostwickCA, et al. (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203: 2895–2906.

20. ShivshankarP, BramptonC, MiyasatoS, KasperM, ThannickalVJ, et al. (2012) Caveolin-1 Deficiency Protects from Pulmonary Fibrosis by Modulating Epithelial Cell Senescence in Mice. Am J Respir Cell Mol Biol 47: 28–36.

21. YamaguchiY, YasuokaH, StolzDB, Feghali-BostwickCA (2011) Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5. J Cell Mol Med 15: 957–969.

22. SchrierDJ, KunkelRG, PhanSH (1983) The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 127: 63–66.

23. HastonCK, AmosCI, KingTM, TravisEL (1996) Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res 56: 2596–2601.

24. TribouletR, MariB, LinYL, Chable-BessiaC, BennasserY, et al. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315: 1579–1582.

25. PottierN, MaurinT, ChevalierB, PuissegurMP, LebrigandK, et al. (2009) Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS ONE 4: e6718 doi:10.1371/journal.pone.0006718

26. PuissegurMP, MazureNM, BerteroT, PradelliL, GrossoS, et al. (2011) miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 18: 465–478.

27. ZarjouA, YangS, AbrahamE, AgarwalA, LiuG (2011) Identification of a microRNA signature in renal fibrosis: Role of miR-21. Am J Physiol Renal Physiol 301: F793–801.

28. LiS, LiangZ, XuL, ZouF (2011) MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem 360: 147–158.

29. Le BrigandK, Robbe-SermesantK, MariB, BarbryP (2010) MiRonTop: mining microRNAs targets across large scale gene expression studies. Bioinformatics 26: 3131–3132.

30. XiaH, KhalilW, KahmJ, JessurunJ, KleidonJ, et al. (2010) Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176: 2626–2637.

31. OdajimaN, BetsuyakuT, NasuharaY, NishimuraM (2007) Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem 55: 899–909.

32. TourkinaE, RichardM, GoozP, BonnerM, PannuJ, et al. (2008) Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 294: L843–L861.

33. KimHP, ChoiAM (2008) Caveolin-1 stops profibrogenic signaling? Am J Physiol Lung Cell Mol Physiol 294: L841–L842.

34. SubramanianA, TamayoP, MoothaVK, MukherjeeS, EbertBL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.

35. LuJ, GetzG, MiskaEA, varez-SaavedraE, LambJ, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838.

36. ZhangC (2008) MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 33: 139–147.

37. XieT, LiangJ, GuoR, LiuN, NoblePW, et al. (2011) Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 43: 479–487.

38. OgawaT, EnomotoM, FujiiH, SekiyaY, YoshizatoK, et al. (2012) MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 61: 1600–1609.

39. LizeM, PilarskiS, DobbelsteinM (2010) E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 17: 452–458.

40. MarcetB, ChevalierB, LuxardiG, CorauxC, ZaragosiLE, et al. (2011) Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway. Nat Cell Biol 13: 693–699.

41. YangH, KongW, HeL, ZhaoJJ, O'DonnellJD, et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425–433.

42. ChakrabartyA, TranguchS, DaikokuT, JensenK, FurneauxH, et al. (2007) MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci U S A 104: 15144–15149.

43. FriedmanLM, DrorAA, MorE, TenneT, TorenG, et al. (2009) MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. Proc Natl Acad Sci U S A 106: 7915–7920.

44. LinEA, KongL, BaiXH, LuanY, LiuCJ (2009) miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem 284: 11326–11335.

45. GarzonR, VoliniaS, LiuCG, Fernandez-CymeringC, PalumboT, et al. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111: 3183–3189.

46. IorioMV, VisoneR, DiLG, DonatiV, PetroccaF, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699–8707.

47. UedaT, VoliniaS, OkumuraH, ShimizuM, TaccioliC, et al. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136–146.

48. MurakamiY, ToyodaH, TanakaM, KurodaM, HaradaY, et al. (2011) The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE 6: e16081 doi:10.1371/journal.pone.0016081

49. KandaT, IshibashiO, KawahigashiY, MishimaT, KosugeT, et al. (2010) Identification of obstructive jaundice-related microRNAs in mouse liver. Hepatogastroenterology 57: 1013–1023.

50. SeversNJ (1988) Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci 90 (Pt 3) 341–348.

51. WilliamsTM, LisantiMP (2004) The Caveolin genes: from cell biology to medicine. Ann Med 36: 584–595.

52. ChenYG, WangXF (2009) A special issue on TGF-beta signaling. Cell Res 19: 1–2.

53. ZhangY, FanKJ, SunQ, ChenAZ, ShenWL, et al. (2012) Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-beta signalling pathway. Nucleic Acids Res 40: 9286–9297.

54. SwaisgoodCM, FrenchEL, NogaC, SimonRH, PloplisVA (2000) The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157: 177–187.

55. BonniaudP, MargettsPJ, KolbM, SchroederJA, KapounAM, et al. (2005) Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 171: 889–898.

56. YamashitaCM, DolgonosL, ZemansRL, YoungSK, RobertsonJ, et al. (2011) Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis. Am J Pathol 179: 1733–1745.

57. RazaniB, WangXB, EngelmanJA, BattistaM, LagaudG, et al. (2002) Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22: 2329–2344.

58. KumarswamyR, VolkmannI, ThumT (2011) Regulation and function of miRNA-21 in health and disease. RNA Biol 8: 706–713.

59. DavisBN, HilyardAC, LagnaG, HataA (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56–61.

60. DavisBN, HilyardAC, NguyenPH, LagnaG, HataA (2010) Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39: 373–384.

61. MooreJ, McKnightAJ, SimmondsMJ, CourtneyAE, HanvesakulR, et al. (2010) Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA 303: 1282–1287.

62. ParkHC, YasudaK, RatliffB, StoesselA, SharkovskaY, et al. (2010) Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted. Am J Physiol Renal Physiol 298: F357–F364.

63. BatallerR, BrennerDA (2005) Liver fibrosis. J Clin Invest 115: 209–218.

64. PottierN, ChupinC, DefamieV, CardinaudB, SutherlandR, et al. (2007) Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3? Am J Respir Crit Care Med 176: 1098–1107.

65. RoderburgC, UrbanGW, BettermannK, VucurM, ZimmermannH, et al. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209–218.

66. DemedtsM, CostabelU (2002) ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J 19: 794–796.

67. SteeleMP, SpeerMC, LoydJE, BrownKK, HerronA, et al. (2005) Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 172: 1146–1152.

68. Griffiths-JonesS, GrocockRJ, vanDS, BatemanA, EnrightAJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140–D144.

69. WuW, DaveN, TsengGC, RichardsT, XingEP, et al. (2005) Comparison of normalization methods for CodeLink Bioarray data. BMC Bioinformatics 6: 309.

70. LeBK, BarbryP (2007) Mediante: a web-based microarray data manager. Bioinformatics 23: 1304–1306.

71. MoothaVK, LindgrenCM, ErikssonKF, SubramanianA, SihagS, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267–273.

72. vanDS, breu-GoodgerC, EnrightAJ (2008) Detecting microRNA binding and siRNA off-target effects from expression data. Nat Methods 5: 1023–1025.

73. RosenbloomJ, CastroSV, JimenezSA (2010) Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 152: 159–166.